Climate change has emerged as one of the most pressing global challenges of our time, with industries across the globe reevaluating their carbon footprints. For the pharmaceutical sector, particularly Active Pharmaceutical Ingredient (API) manufacturing, sustainability is no longer an option
low carbon building market report includes region like North America (U.S, Canada, Mexico), Europe (Germany, United Kingdom, France, Italy, Spain, Netherlands, Turkey), Asia-Pacific (China, Japan, Malaysia, South Korea, India, Indonesia, Australia), South America (Brazil, Argentina), Middle-East (Saudi Arabia, UAE, Kuwait,
Regeneration starts with building relationships, not regulations. Carbon has become a currency: a unit to trade, a number to reduce, a quota to meet. Governments and corporations are building frameworks to monitor, tax, and limit carbon, and while the intention
Bridging the CDR Market and the Agricultural Sector: A Dual Value Proposition There’s something daunting about thinking of carbon only as a problem to be resolved; as a waste to be cleaned up from our atmosphere. This feeling doesn’t get
The new normal? There’s been a subtle shift amongst UK land managers in recent years, away from climate mitigation and towards climate adaptation. A growing realization that global heating has already completely changed our climate and that this change is
Carbon dioxide removal (#CDR) has officially entered its make-or-break decade. No longer an experimental concept, it now sits at the heart of net-zero strategies, industrial innovation, and climate credibility. In 2025, the global conversation is no longer about if CDR